Metadata
Author: Literature
Data
English[en]
There is no apparent additional antithrombotic benefit in venous thromboembolism with a target INR above 2.0–3.0.
Spanish[es]
No hay un beneficio antitrombótico adicional aparente en la tromboembolia venosa con una INR ideal mayor de 2.0 a 3.0.